pocketful logo light
pocketful logo light
Mangalam Drugs and Organics Ltd logo

Mangalam Drugs and Organics Ltd

NSE: MANGALAM BSE: 532637

₹28.76

(0.24%)

Wed, 03 Jun 2026, 06:06 pm

mtf coin illustrationMTF 5x

Company History

1972

  • The company was promoted by Dhoot family as Advent Pharma Private Limited.

1977

  • The first plant for manufacture of perfumery chemicals at Plot No. 187, GIDC, Vapi was started under the name Advent Pharma Pvt. Ltd.

1981

  • A new plant was commissioned under the name Mangalam Rasayan Pvt. Ltd. for manufacture of Anhydrous Aluminium Chloride.

1984

  • A new plant was commissioned under the name Shree Mangalam Pharma Pvt. Ltd. for manufacture of Aromatic Chemicals.
  • The facilities in APPL were re-organised to manufacture the first Bulk Drug, Metronidazole I.P.

1985

  • The capacity of Anhydrous Aluminium Chloride was doubled.

1987

  • Inorganic chemicals manufacturing capacities were expanded by putting up a new plant at Sangamner under the name Mangalam Inorganics Pvt. Ltd.

1989

  • A new plant was erected to manufacture Dyes Intermediates at Plot No. 1203, IIIrd Phase, GIDC, Vapi under the name Mangalam Organics Private Ltd.

1991

  • Additional manufacturing capacity for perfumery chemicals was created under a new plant of SMPPL.

1994

  • A new plant was commissioned for manufacturing Meta Chloro Aniline under MRPL.

1996

  • Three group companies, Mangalam Organics Private Limited, Shree Mangalam Pharma Private Limited and Mangalam Rasayan Private Limited, were merged with Advent Pharma Private Limited.

1997

  • A scheme of arrangement was implemented between SMPPL, MOPL and MRPL, transferring their entire Chemical Division to Mangalam Drugs & Organics Ltd.
  • The company became a deemed public limited company.

1999

  • A new product, Nimesulide, was launched from Plant at Plot No. 1203.

2001

  • Two new products, Amodiaquine Hydrochloride and Amodiaquine, were launched from Plant at Plot No.1203.
  • The company was converted into a full-fledged public limited company.

2002

  • WHO-GMP approval was received for Chloroquine Phosphate I.P./B.P.
  • The company was awarded ISO-9000-2000 Management System Certificate from DNV.

2003

  • WHO-GMP approval was received for Amodiaquine Hydrochloride and Amodiaquine U.S.P.
  • The company was awarded ISO-9000-2000 Management System Certificate from DNV.

2005

  • Mangalam Drugs and Organics Ltd filed a prospectus with Securities Exchange Board of India to raise Rs 14.3 crore through a public issue.
  • Shares of Mangalam Drugs & Organics Ltd made their debut on the Bombay Stock Exchange at Rs 30.

2006

  • The Company recommended a Final Dividend of Re 0.20 ps (2%) per Equity Share.

2009

  • Mr. Mukul Sukhani was appointed as Additional Director on the Board of the Company.

2014

  • Mrs Meenal Sukhani was appointed as Additional Director on the Board of the Company.
  • The registered office of the company was shifted from Princess Street Near Flyover Bridge, Marine Lines, Mumbai to 3rd Floor, Rupam Building, 237, P. D. Mello Road, Mumbai - 400001, Maharashtra.